Density histogram analysis of unenhanced hepatic computed tomography in patients with diffuse liver diseases

Journal of Computer Assisted Tomography

Volumn 30, Issue 2, 2006, Pages 201-205

  Fritz, Gerald A ^a   Schoellnast, Helmut ^a   Deutschmann, Hannes A ^a   Wiltgen, Marco ^b   Brader, Peter ^a   Berghold, Andrea ^b   Groell, Reinhard ^a  

^a UNIVERSITY HOSPITAL GRAZ   (Austria)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Computed tomography; Density histogram; Diffuse liver diseases; Hepatic attenuation

Indexed keywords

COMPUTERIZED TOMOGRAPHY; GRAPHIC METHODS; HIGHER ORDER STATISTICS; VIRUSES;

COMPUTED TOMOGRAPHY; DENSITY HISTOGRAM; DIFFUSE LIVER DISEASE; HAEMOCHROMATOSIS; HEPATIC ATTENUATION; HISTOGRAM ANALYSIS; KURTOSIS AND SKEWNESS; LIVER DISEASE;

DIAGNOSIS;

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; FATTY LIVER; FEMALE; HEMOCHROMATOSIS; HISTOGRAM; HUMAN; LIVER CIRRHOSIS; LIVER DISEASE; LIVER PARENCHYMA; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

EID: 33646705165     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004728-200603000-00006     Document Type: Article

References (40)

1. Aburano T, Yokoyama K, Shuke N, et al. 99mTc colloid and 99mTc IDA imagings in diffuse hepatic disease. J Clin Gastroenterol. 1993;17:321-326.
2. Blomley MJ, Coulden R, Dawson P, et al. Liver perfusion studied with ultrafast CT. J Comput Assist Tomogr. 1995;19:424-433.
3. Bydder GM, Chapman RW, Harry D, et al. Computed tomography attenuation values in fatty liver. J Comput Tomogr. 1981;5:33-35.
4. Chen JH, Chai JW, Shen WC. Magnetization transfer contrast imaging of liver cirrhosis. Hepatogastroenterology. 1999;46:2872-2877.
5. Joseph AE, Saverymuttu SH, al Sam S, et al. Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol. 1991;43:26-31.
6. Keevil SF, Alstead EM, Dolke G, et al. Non-invasive assessment of diffuse liver disease by in vivo measurement of proton nuclear magnetic resonance relaxation times at 0.08 T. Br J Radiol. 1994;67:1083-1087.
7. Longo R, Ricci C, Masutti F, et al. Fatty infiltration of the liver. Quantification by 1H localized magnetic resonance spectroscopy and comparison with computed tomography. Invest Radiol. 1993;28:297-302.
8. Mendler MH, Bouillet P, Le Sidaner A, et al. Dual-energy CT in the diagnosis and quantification of fatty liver: limited clinical value in comparison to ultrasound scan and single-energy CT, with special reference to iron overload. J Hepatol. 1998;28:785-794.
9. Morijiri M, Seto H, Kamisaki Y, et al. Qualitative evaluation of chronic diffuse liver disease by STIR MRI. J Comput Assist Tomogr. 1995;19:955-958.
10. Murakami T, Baron RL, Federle MP, et al. Cirrhosis of the liver: MR imaging with mangafodipir trisodium (Mn-DPDP). Radiology. 1996;198:567-572.
11. Partanen KP. Dynamic CT of liver cirrhosis. Invest Radiol. 1984;19:303-308.
12. Shiomi S, Kuroki T, Jomura H, et al. Diagnosis of chronic liver disease from liver scintiscans by fuzzy reasoning. J Nucl Med. 1995;36:593-598.
13. Steinmaurer HJ, Jirak P, Walchshofer J, et al. Accuracy of sonography in the diagnosis of diffuse liver parenchymal diseases-comparison of sonography and liver histology [in German]. Ultraschall Med. 1984;5:98-103.
14. Sugano S, Okajima T, Kubo S, et al. Evaluation of hepatic density change by dynamic CT in healthy humans and in patients with chronic liver diseases. Dig Dis Sci. 1992;37:220-224.
15. Suzuki K, Hayashi N, Sasaki Y, et al. Evaluation of structural change in diffuse liver disease with frequency domain analysis of ultrasound. Hepatology. 1993;17:1041-1046.
16. Takayasu K, Yoshie K, Muramatsu Y, et al. Haemodynamic changes in non-alcoholic (viral) liver cirrhosis studied by computed tomography (CT) arterial portography and CT arteriography. J Gastroenterol Hepatol. 1999;14:908-914.
17. Uematsu H, Yamada H, Sadato N, et al. Assessment of hepatic portal perfusion using T2 measurements of Gd-DTPA. J Magn Reson Imaging. 1998;8:650-654.
18. Van Beers BE, Leconte I, Materne R, et al. Hepatic perfusion parameters in chronic liver disease: dynamic CT measurements correlated with disease severity. AJR Am J Roentgenol. 2001;176:667-673.
19. Vogl T, Steiner S, Hahn D, et al. Diffuse liver parenchymal diseases: the value of MRI compared to sonography and CT [in German]. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr. 1991;154:495-503.
20. Mergo PJ, Ros PR, Buetow PC, et al. Diffuse disease of the liver: radiologic-pathologic correlation. Radiographics. 1994;14:1291-1307.
21. Mergo PJ, Ros PR. Imaging of diffuse liver disease. Radiol Clin North Am. 1998;36:365-375.
22. Mortele KJ, Ros PR. Imaging of diffuse liver disease. Semin Liver Dis. 2001;21:195-212.
23. Tani I, Kurihara Y, Kawaguchi A, et al. MR imaging of diffuse liver disease. AJR Am J Roentgenol. 2000;174:965-971.
24. Martin DR. Magnetic resonance imaging of diffuse liver diseases. Top Magn Reson Imaging. 2002;13:151-163.
25. Graif M, Yanuka M, Baraz M, et al. Quantitative estimation of attenuation in ultrasound video images: correlation with histology in diffuse liver disease. Invest Radiol. 2000;35:319-324.
26. Tacikowski T, Walewska-Zielecka B, Dzieniszewski J. Computerized tomography in the diagnosis of nonalcoholic fatty liver-comparison with liver biopsy [in Polish]. Pol Arch Med Wewn. 2004;111:571-577.
27. Lenhart M, Feuerbach S. Role of computed tomography and magnetic resonance imaging in the diagnosis of hepatitis and liver cirrhosis [in German]. Schweiz Rundsch Med Prax. 2005;94:635-638.
28. Do KH, Lee JS, Colby TV, et al. Nonspecific interstitial pneumonia versus usual interstitial pneumonia: differences in the density histogram of high-resolution CT. J Comput Assist Tomogr. 2005;29:544-548.
29. Sverzellati N, Zompatori M, Luca GD, et al. Evaluation of quantitative CT indexes in idiopathic interstitial pneumonitis using a low-dose technique. Eur J Radiol. 2005;56:370-375.
30. Uppaluri R, Mitsa T, Sonka M, et al. Quantification of pulmonary emphysema from lung computed tomography images. Am J Respir Crit Care Med. 1997;156:248-254.
31. Hartley PG, Galvin JR, Hunninghake GW, et al. High-resolution CT-derived measures of lung density are valid indexes of interstitial lung disease. J Appl Physiol. 1994;76:271-277.
32. Pindyck RS, Rubinfeld DL. Elementary statistics: a review. Econometrics Models and Economic Forecasts. Boston: McGraw-Hill/Irwin; 1997:46-47.
33. Matteoni CA, Younossi ZM, Gramlich T, et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 1999;116:1413-1419.
34. Teli MR, James OF, Burt AD, et al. The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology. 1995;22:1714-1719.
35. Cortez-Pinto H, Baptista A, Camilo ME, et al. Nonalcoholic steatohepatitis-a long-term follow-up study: comparison with alcoholic hepatitis in ambulatory and hospitalized patients. Dig Dis Sci. 2003;48:1909-1913.
36. Ikeda K, Saitoh S, Koida I, et al. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology. 1993;18:47-53.
37. Kato Y, Nakata K, Omagari K, et al. Risk of hepatocellular carcinoma in patients with cirrhosis in Japan. Analysis of infectious hepatitis viruses. Cancer. 1994;74:2234-2238.
38. Piekarski J, Goldberg HI, Royal SA, et al. Difference between liver and spleen CT numbers in the normal adult: its usefulness in predicting the presence of diffuse liver disease. Radiology. 1980;137:727-729.
39. Lieber CS. Liver disease and alcohol: fatty liver, alcoholic hepatitis, cirrhosis, and their interrelationships. Ann NY Acad Sci. 1975;252:63-84.
40. Maddrey WC. Alcoholic hepatitis: clinicopathologic features and therapy. Semin Liver Dis. 1988;8:91-102.